{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:39Z","timestamp":1792068879716,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118807","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:49:53Z","timestamp":1790135393000},"page":"118807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of novel dihydropyrimidinone imines as potent anticancer agents targeting AKT to induce cell cycle arrest and apoptosis in breast Cancer cells"],"prefix":"10.1016","volume":"143","author":[{"given":"Marian N.","family":"Gerges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Noser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman G.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoria","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118807_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18030361","article-title":"A decade of innovation in breast cancer (2015\u20132025): a comprehensive review of clinical trials, targeted therapies and molecular perspectives","volume":"18","author":"Dynarowicz","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2026.118807_bb0010","series-title":"Patient Navigation for Early Detection, Diagnosis and Treatment of Breast cancer: Technical Brief","author":"W.H. Organization","year":"2024"},{"key":"10.1016\/j.bmc.2026.118807_bb0015","first-page":"1","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2026.118807_bb0020","series-title":"Current trends in breast Cancer pathology, screening, diagnosis and treatments","first-page":"1","article-title":"Breast cancer: definition, history, symptoms, causes, worldwide scenario, global statistics","author":"Khan","year":"2026"},{"key":"10.1016\/j.bmc.2026.118807_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1773232","article-title":"Breast cancer pathogenesis, diagnosis and treatment: a comprehensive review","volume":"16","author":"Pasi","year":"2026","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2026.118807_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/GCO.0000000000000927","article-title":"New strategies for the management of triple-negative breast cancer","volume":"36","author":"Riaz","year":"2024","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.bmc.2026.118807_bb0035","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/cancers17071082","article-title":"Exploring the genetic Orchestra of Cancer: the interplay between oncogenes and tumor-suppressor genes","volume":"17","author":"Singh","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2026.118807_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","article-title":"RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms","volume":"17","author":"Yang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bmc.2026.118807_bb0045","series-title":"Translational Research in Breast Cancer","first-page":"81","article-title":"Ras Signaling in Breast cancer","author":"Moon","year":"2021"},{"key":"10.1016\/j.bmc.2026.118807_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/5584_2024_832","article-title":"PI3K signaling at the crossroads of lipid metabolism and Cancer","volume":"1479","author":"Yilmaz","year":"2025","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bmc.2026.118807_bb0055","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-24-1846","article-title":"AKT and the hallmarks of Cancer","volume":"84","author":"Sementino","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118807_bb0060","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3390\/cancers13143517","article-title":"Targeting PI3K\/AKT\/mTOR signaling pathway in breast cancer","volume":"13","author":"Li","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2026.118807_bb0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118807_bb0070","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/s41467-025-59210-6","article-title":"Capivasertib plus fulvestrant in patients with HR-positive\/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort","volume":"16","author":"Hu","year":"2025","journal-title":"Nat Commun"},{"issue":"Pt 7","key":"10.1016\/j.bmc.2026.118807_bb0075","doi-asserted-by":"crossref","first-page":"127375","DOI":"10.1016\/j.ijbiomac.2023.127375","article-title":"A review of glycogen synthase kinase-3 (GSK3) inhibitors for cancers therapies","volume":"253","author":"Thapa","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2026.118807_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118659","article-title":"GSK-3\u03b2 in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer","volume":"1867","author":"Lin","year":"2020","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Res"},{"key":"10.1016\/j.bmc.2026.118807_bb0085","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3390\/ijms23031709","article-title":"Regulation of autophagy by the glycogen synthase kinase-3 (GSK-3) signaling pathway","volume":"23","author":"Pan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118807_bb0090","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1038\/s41598-024-53517-y","article-title":"Synthesis and molecular docking simulations of novel azepines based on quinazolinone moiety as prospective antimicrobial and antitumor hedgehog signaling inhibitors","volume":"14","author":"Noser","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118807_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138735","article-title":"New thiadiazolopyrimidine-ornamented pyrazolones as prospective anticancer candidates via suppressing VEGFR-2\/PI3K\/Akt signaling pathway: synthesis, characterization, in-silico, and in-vitro studies","volume":"289","author":"Salem","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2026.118807_bb0100","first-page":"1","article-title":"Advanced pyrimidinone chemistry: a comprehensive review of synthetic pathways and biological potency","author":"Noser","year":"2026","journal-title":"Chem Pap"},{"key":"10.1016\/j.bmc.2026.118807_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13065-018-0440-3","article-title":"Design, synthesis, antimicrobial and cytotoxicity study on human colorectal carcinoma cell line of new 4, 4\u2032-(1, 4-phenylene) bis (pyrimidin-2-amine) derivatives","volume":"12","author":"Kumar","year":"2018","journal-title":"Chem Cent J"},{"key":"10.1016\/j.bmc.2026.118807_bb0110","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1080\/07391102.2021.1961867","article-title":"Molecular dynamics simulation, synthesis and topoisomerase inhibitory actions of vanillin derivatives: a systematic computational structural integument","volume":"40","author":"Sahoo","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2026.118807_bb0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/asia.201801560","article-title":"Carbonyl compounds\u2019 journey to amide bond formation","volume":"14","author":"Narendar Reddy","year":"2019","journal-title":"Chem Asian J"},{"key":"10.1016\/j.bmc.2026.118807_bb0120","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1039\/D5MD00139K","article-title":"Novel furo[2,3-d]pyrimidine derivatives as PI3K\/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulation","volume":"16","author":"Reheim","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0125","doi-asserted-by":"crossref","first-page":"22146","DOI":"10.1038\/s41598-022-26571-7","article-title":"Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS\/PI3K\/Akt\/JNK inhibition in breast carcinoma cells","volume":"12","author":"Salem","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118807_bb0130","doi-asserted-by":"crossref","first-page":"1577044","DOI":"10.3389\/fmolb.2025.1577044","article-title":"Metformin modulates oxidative stress via activation of AMPK\/NF-\u03baB signaling in trisomy 21 fibroblasts: an in vitro study","volume":"12","author":"Buczy\u0144ska","year":"2025","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.bmc.2026.118807_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.14499\/indonesianjpharm25iss4pp245","article-title":"Optimization of sodium dodecyl sulphate as a formazan solvent and comparison of 3-(4,-5-dimethylthiazo-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay with wst-1 assay in mcf-7 cells","volume":"25","author":"Septisetyani","year":"2014","journal-title":"Indones J Pharm"},{"key":"10.1016\/j.bmc.2026.118807_bb0140","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2026.118807_bb0145","series-title":"Analysis of cellular DNA content by flow and laser scanning cytometry, polyploidization and cancer","first-page":"137","author":"Darzynkiewicz","year":"2010"},{"key":"10.1016\/j.bmc.2026.118807_bb0150","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biochi.2012.12.001","article-title":"Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines","volume":"95","author":"Maioral","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2026.118807_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2026.118807_bb0160","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14789450.2017.1388167","article-title":"Protein purification and analysis: next generation Western blotting techniques","volume":"14","author":"Mishra","year":"2017","journal-title":"Expert Rev Proteom"},{"key":"10.1016\/j.bmc.2026.118807_bb0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bmc.2026.118807_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2026.110183","article-title":"An environmentally relevant phthalate mixture impairs ovulatory prostaglandin and progesterone receptor pathways in human granulosa cells in vitro","volume":"209","author":"Land","year":"2026","journal-title":"Environ Int"},{"key":"10.1016\/j.bmc.2026.118807_bb0175","first-page":"51046","article-title":"In vitro cell migration and invasion assays","volume":"88","author":"Justus","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bmc.2026.118807_bb0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ddr.21673","article-title":"Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein\u2013ligand recognition process","volume":"81","author":"Sivakumar","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2026.118807_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","article-title":"A drug-likeness toolbox facilitates ADMET study in drug discovery","volume":"25","author":"Jia","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2026.118807_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2026.118807_bb0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.bmc.2026.118807_bb0200","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.4007","article-title":"Cell viability and cytotoxicity assays: biochemical elements and cellular compartments","volume":"42","author":"Khalef","year":"2024","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.bmc.2026.118807_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038508","article-title":"HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.bmc.2026.118807_bb0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1535-7163.MCT-13-0681","article-title":"Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer","volume":"13","author":"Pal","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2026.118807_bb0220","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1038\/srep10027","article-title":"Breast cancer cell line MCF7 escapes from G1\/S arrest induced by proteasome inhibition through a GSK-3\u03b2 dependent mechanism","volume":"5","author":"Gavil\u00e1n","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118807_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4062\/biomolther.2017.042","article-title":"Panduratin a inhibits cell proliferation by inducing G0\/G1 phase cell cycle arrest and induces apoptosis in breast Cancer cells","volume":"26","author":"Liu","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.bmc.2026.118807_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173850","article-title":"Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3, 4-dihydropyrimidin-2 (1H)-one C5 amide derivatives","volume":"894","author":"Moosavi","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2026.118807_bb0235","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/CAD.0b013e3282ef4571","article-title":"Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells","volume":"18","author":"Bar-On","year":"2007","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bmc.2026.118807_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107759","article-title":"Mitigating the resistance of MCF-7 cancer cells to doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors","volume":"152","author":"Abdelaal","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0245","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1039\/D3MD00682D","article-title":"In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer","volume":"15","author":"Carvalho","year":"2024","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0250","doi-asserted-by":"crossref","first-page":"21042","DOI":"10.1021\/acsomega.4c00466","article-title":"Triggering breast cancer apoptosis via cyclin-dependent kinase inhibition and DNA damage by novel pyrimidinone and 1, 2, 4-triazolo [4, 3-a] pyrimidinone derivatives","volume":"9","author":"Abd Al Moaty","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2026.118807_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118807_bb0260","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2026.118807_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116500","article-title":"Discovery of novel small molecules targeting the USP21\/JAK2\/STAT3 axis for the treatment of triple-negative breast cancer","volume":"273","author":"Long","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0270","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3389\/fonc.2019.01199","article-title":"RAS as supporting actor in breast cancer","volume":"9","author":"Gali\u00e8","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2026.118807_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071094","article-title":"The importance of being PI3K in the RAS signaling network","volume":"12","author":"Cuesta","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bmc.2026.118807_bb0280","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s12276-023-01067-0","article-title":"Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling","volume":"55","author":"Oh","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.bmc.2026.118807_bb0285","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12885-018-4282-0","article-title":"Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer","volume":"18","author":"Banys-Paluchowski","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bmc.2026.118807_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051110","article-title":"Targeting GSK3 and associated signaling pathways involved in Cancer","volume":"9","author":"Duda","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118807_bb0295","first-page":"285","article-title":"Downregulation of GSK3B by miR-132-3p enhances etoposide-induced breast cancer cell apoptosis","volume":"51","author":"Xu","year":"2021","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.bmc.2026.118807_bb0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14756366.2020.1862101","article-title":"Novel oxindole\/benzofuran hybrids as potential dual CDK2\/GSK-3\u03b2 inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies","volume":"36","author":"Eldehna","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0305","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.febslet.2012.09.011","article-title":"NOK\/STYK1 interacts with GSK-3\u03b2 and mediates Ser9 phosphorylation through activated Akt","volume":"586","author":"Li","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2026.118807_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajco.14125","article-title":"Xanthine negatively regulates c-MYC through the PI3K\/AKT signaling pathway and inhibits the proliferation, invasion, and migration of breast cancer cells","volume":"21","author":"Zhang","year":"2025","journal-title":"Asia-Pac J Clin Oncol"},{"key":"10.1016\/j.bmc.2026.118807_bb0315","doi-asserted-by":"crossref","first-page":"21240","DOI":"10.18632\/oncotarget.4067","article-title":"p53 attenuates AKT signaling by modulating membrane phospholipid composition","volume":"6","author":"Rueda-Rincon","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2026.118807_bb0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s43440-024-00658-6","article-title":"c-Myc inhibition and p21 modulation contribute to unsymmetrical bisacridines-induced apoptosis and senescence in pancreatic cancer cells","volume":"77","author":"Kurdyn","year":"2025","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2026.118807_bb0325","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/MCB.01461-06","article-title":"Glycogen synthase kinase 3\u03b2 phosphorylates p21WAF1\/CIP1 for proteasomal degradation after UV irradiation","volume":"27","author":"Lee","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2026.118807_bb0330","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4629495","article-title":"Multifaceted roles of GSK-3 in cancer and autophagy-related diseases","volume":"2017","author":"Mancinelli","year":"2017","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.bmc.2026.118807_bb0335","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/cells10040816","article-title":"GSK-3\u03b2 can regulate the sensitivity of MIA-PaCa-2 pancreatic and MCF-7 breast cancer cells to chemotherapeutic drugs, targeted therapeutics and nutraceuticals","volume":"10","author":"Abrams","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118807_bb0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/cancers14020279","article-title":"Regulation of Bcl-2 family proteins in estrogen receptor-positive breast cancer and their implications in endocrine therapy","volume":"14","author":"Kawiak","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2026.118807_bb0345","article-title":"Genetic silencing of AKT induces melanoma cell death","author":"Parkman","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.bmc.2026.118807_bb0350","doi-asserted-by":"crossref","first-page":"1516583","DOI":"10.3389\/fphar.2025.1516583","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in lung cancer: mechanisms and therapeutic targeting","volume":"16","author":"Qiang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2026.118807_bb0355","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41401-023-01093-8","article-title":"Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies","volume":"44","author":"Su","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmc.2026.118807_bb0360","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/genes12060819","article-title":"The crossroads between RAS and RHO signaling pathways in cellular transformation, motility and contraction","volume":"12","author":"Soriano","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.bmc.2026.118807_bb0365","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13058-019-1125-0","article-title":"GSK3\u03b2 regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer","volume":"21","author":"Vijay","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmc.2026.118807_bb0370","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/cells9051110","article-title":"Targeting GSK3 and associated signaling pathways involved in cancer","volume":"9","author":"Duda","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118807_bb0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-021-01452-5","article-title":"Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src family non-receptor tyrosine kinases","volume":"23","author":"Mohammed","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmc.2026.118807_bb0380","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4048\/jbc.2019.22.e22","article-title":"Doxorubicin promotes migration and invasion of breast cancer cells through the upregulation of the RhoA\/MLC pathway","volume":"22","author":"Liu","year":"2019","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.bmc.2026.118807_bb0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/2211-5463.13330","article-title":"Doxorubicin promotes breast cancer cell migration and invasion via DCAF13","volume":"12","author":"Sun","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bmc.2026.118807_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111593","article-title":"Design, synthesis, in vitro, and in silico studies of new N(5)-substituted-pyrazolo[3,4-d]pyrimidinone derivatives as anticancer CDK2 inhibitors","volume":"16","author":"Zaki","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmc.2026.118807_bb0395","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42137-7","article-title":"Simple dihydropyridine-based colorimetric chemosensors for heavy metal ion detection, biological evaluation, molecular docking, and ADMET profiling","volume":"13","author":"Hamada","year":"2023","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.bmc.2026.118807_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400449","article-title":"A novel fluorescent probe containing dihydropyrimidinone analogue for highly sensitive, selective detection of Al(III) ions with its molecular docking, ADME\/T and anticancer impact","volume":"9","author":"El-Nahass","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2026.118807_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109686","article-title":"Synthesis of novel optical chemosensors for solvatochromic behavior, metal ions recognition and anticancer applications","volume":"174","author":"Khairat","year":"2026","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118807_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140783","article-title":"Discovery of novel azo pyrimidinone derivatives as B-cell lymphoma-2 inhibitors with potential antineoplastic activity: synthesis, characterization, in-silico, and in-vitro studies","volume":"1323","author":"Noser","year":"2025","journal-title":"J Mol Struct"},{"issue":"20","key":"10.1016\/j.bmc.2026.118807_bb0415","doi-asserted-by":"crossref","DOI":"10.1002\/slct.73537","article-title":"Multi-technique investigation of pyrimidine-2-thione azo dyes as AKT signaling inhibitors: synthesis, NCI, ELF, LOL, molecular docking, and ADMET studies","volume":"11","author":"Noser","year":"2026","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2026.118807_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106520","article-title":"Novel Coumarin-furo[2,3-d]pyrimidinone hybrid derivatives as anticancer agents: synthesis, biological evaluation and molecular docking","volume":"188","author":"Jin","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmc.2026.118807_bb0425","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1021\/acs.jmedchem.0c02093","article-title":"Discovery of a pyrimidinedione derivative as a potent and orally bioavailable Axl inhibitor","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:37:26Z","timestamp":1792067846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":85,"alternative-id":["S0968089626002634"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118807","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of novel dihydropyrimidinone imines as potent anticancer agents targeting AKT to induce cell cycle arrest and apoptosis in breast Cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118807"}}